Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,041 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,668 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01177501 | Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma(ITOV04) | terminated | Phase 1 | 3 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 19, 2012 | clinicaltrials |
| NCT01226888 | Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer | terminated | — | 2 | Massachusetts General HospitalOTHER | 1 | Nov 5, 2012 |
| clinicaltrials |
| NCT00919022 | Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate(ANES) | terminated | — | 194 | BayerINDUSTRY | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00714376 | Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients(TAX1) | terminated | Phase 2 | 6 | CHU de Quebec-Universite LavalOTHER | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00293371 | Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 6 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00313534 | Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer | terminated | Phase 1 | 15 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00379119 | Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer | terminated | — | 20 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00288275 | Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer | terminated | — | 256 | Precision TherapeuticsINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00669422 | ChemoFx® PRO - A Post-Market Data Collection Study | terminated | — | 2,756 | Precision TherapeuticsINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | terminated | Phase 2 | 2 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer(ETC) | terminated | Phase 1 / Phase 2 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00006356 | Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer | terminated | Phase 3 | 38 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00014586 | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | terminated | Phase 3 | 110 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00496080 | Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding(DUAO) | terminated | N/A | 87 | Ethicon, Inc.INDUSTRY | 3 | Sep 10, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00516841 | A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer | terminated | Phase 2 | 16 | Facet BiotechINDUSTRY | 2 | Aug 23, 2012 | clinicaltrials |
| NCT00450970 | Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)(SPERA) | terminated | Phase 3 | 344 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00388804 | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | terminated | Phase 3 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00147238 | A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast | terminated | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00085384 | PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer | terminated | Phase 1 / Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00511758 | Digital Imaging Aid for Assessment of Cervical Dysplasia | terminated | — | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00901420 | Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00897806 | Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | terminated | — | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00058266 | Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy | terminated | Phase 2 | 36 | Northwestern UniversityOTHER | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00471718 | ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | terminated | Phase 1 / Phase 2 | 27 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00127387 | Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia | terminated | Phase 2 / Phase 3 | 54 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00445549 | Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | terminated | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00881725 | A Study of Pre-operative Metformin in Prostate Cancer(ANIMATE) | terminated | Phase 2 | 24 | University Health Network, TorontoOTHER | 1 | Jun 19, 2012 | clinicaltrials |
| NCT00006262 | Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00048659 | YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 10 | Jun 7, 2012 | clinicaltrials |
| NCT00050297 | YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 7 | Jun 7, 2012 | clinicaltrials |
| NCT00073970 | Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | terminated | Phase 2 | 37 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT00653328 | Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma | terminated | Phase 2 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT00313456 | A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel | terminated | Phase 1 | 25 | AgennixINDUSTRY | 1 | May 10, 2012 | clinicaltrials |
| NCT00294437 | ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases | terminated | Phase 3 | 376 | Central European Cooperative Oncology GroupOTHER | 16 | May 1, 2012 | clinicaltrials |
| NCT00911027 | SonoVue Guided Prostate Biopsy | terminated | Phase 3 | 282 | Bracco Diagnostics, IncINDUSTRY | 7 | Apr 25, 2012 | clinicaltrials |
| NCT00231829 | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | terminated | Phase 2 | 23 | Mark H. EinsteinOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00505661 | Letrozole in Patients With Ovarian Tumors | terminated | Phase 2 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 18, 2012 | clinicaltrials |
| NCT00820287 | Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk | terminated | N/A | 44 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00480623 | A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence | terminated | Phase 1 | — | AgennixINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01340599 | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | terminated | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00773318 | SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer | terminated | N/A | 30 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | terminated | Phase 1 | 8 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01096381 | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | terminated | — | 8 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00585741 | Pilot Study of 18F-FLT PET | terminated | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Feb 23, 2012 | clinicaltrials |
| NCT01132404 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | terminated | Phase 1 / Phase 2 | 9 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01510288 | Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | terminated | Phase 1 | 28 | Amsterdam UMC, location VUmcOTHER | 1 | Jan 16, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Nov 19, 2012source: clinicaltrials